External Oblique Intercostal Block (EOICB) for Laparoscopic Cholecystectomy

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-65
SponsorCukurova University

About this trial

This single-center, prospective, randomized controlled trial aims to compare the effects of paravertebral block (PVB), external oblique intercostal (EOI) block, and intravenous patient-controlled analgesia (PCA) with tramadol on postoperative pain and opioid consumption in patients undergoing elective laparoscopic cholecystectomy. The primary endpoint is total tramadol consumption within 24 hours postoperatively. Secondary outcomes include pain scores, additional analgesic use, incidence of nausea/vomiting, mobilization time, and length of hospital stay.

Eligibility criteria

Qualifiers

Age between 18 and 65 years

Scheduled for elective laparoscopic cholecystectomy under general anesthesia

ASA physical status I-III

Able to understand the study procedure and provide informed consent

Disqualifiers

None

Trial design

Treatments tested in this trial

  • Paravertebral Block (PVB)
  • External Oblique Intercostal Block (EOI Block)
  • Tramadol IV Patient-Controlled Analgesia (PCA)

Treatment groups

147 Participants
are divided into 3 treatment groups

Sponsors and collaborators